Related Experiment Video
Updated: Feb 9, 2026

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
Published on: March 29, 2018
Trapidil induces osteogenesis by upregulating the signaling of bone morphogenetic proteins
Bongjun Kim1, Jong-Ho Lee2, Won Jong Jin1
1Department of Cell and Developmental Biology, Dental Research Institute, School of Dentistry, Seoul National University, Seoul 110-749, Republic of Korea.
Abstract:
Platelet-derived growth factor receptor (PDGFR) signaling has been shown to inhibit osteogenesis. However, therapeutic efficacy of inhibiting PDGF signaling to bone regeneration in vivo and the specific mechanisms by which PDGFR signaling inhibits osteogenic differentiation remain unclear. In the present study, we examined the osteogenic effect of inhibiting PDGFR using trapidil, a PDGFR antagonist, in vivo and in vitro, and evaluated its mechanisms. A rat calvarial defect model was analyzed by micro-computed tomography and histology to determine the pro-osteogenic effect of trapidil in vivo. In addition, primary mouse calvarial osteoblast precursors were cultured in osteogenic differentiation medium with trapidil to study the mechanisms. Trapidil greatly promoted bone regeneration in a rat calvarial defect model and osteogenic differentiation of calvarial osteoblast precursors. For the mechanisms, trapidil induced phosphorylation of Smad1/5/9 and mitogen-activated protein kinase (MAPK) leading to enhance expression of Runx2, crucial transcription factor for osteogenesis. The pro-osteogenic effects of trapidil were inhibited by LDN193189, specific inhibitor of bone morphogenetic protein (BMP) receptor, ALK2 and ALK3, and by depletion of ALK3, and treatment with noggin, an antagonist of BMPs. Moreover, trapidil showed a synergistic effect with BMP2 on osteogenic differentiation. In conclusion, trapidil induced BMPR activity through upregulation of BMP signaling, leading to promoted osteogenesis in vitro and in vivo. Attenuated BMPR activity may be involved in the inhibition of osteogenesis by PDGFR signaling.
Insights
Inhibiting platelet-derived growth factor receptor (PDGFR) with trapidil significantly enhances bone regeneration and osteogenic differentiation. This occurs by upregulating bone morphogenetic protein receptor (BMPR) activity, promoting osteogenesis in vitro and in vivo.
Area of Science:
- Regenerative Medicine
- Orthopedics
- Molecular Biology
Background:
- Platelet-derived growth factor receptor (PDGFR) signaling is known to inhibit osteogenesis.
- The therapeutic potential of PDGFR inhibition for bone regeneration and its precise inhibitory mechanisms remain largely unelucidated.
Purpose of the Study:
- To investigate the osteogenic effects of inhibiting PDGFR using trapidil, a PDGFR antagonist, in both in vivo and in vitro models.
- To elucidate the underlying molecular mechanisms by which PDGFR inhibition promotes osteogenesis.
Main Methods:
- A rat calvarial defect model was utilized to assess in vivo bone regeneration using micro-computed tomography and histology.
- Primary mouse calvarial osteoblast precursors were cultured in osteogenic differentiation medium with trapidil to examine cellular mechanisms.
- Western blotting and specific inhibitors (LDN193189, noggin) were employed to investigate signaling pathways, including BMP and MAPK.
Main Results:
- Trapidil significantly promoted bone regeneration in the rat calvarial defect model and enhanced osteogenic differentiation of osteoblast precursors.
- Mechanistically, trapidil induced phosphorylation of Smad1/5/9 and MAPK, leading to increased Runx2 expression, a key transcription factor for osteogenesis.
- The pro-osteogenic effects of trapidil were dependent on bone morphogenetic protein receptor (BMPR) activity, as evidenced by inhibition with LDN193189, ALK3 depletion, and noggin treatment. Trapidil also showed a synergistic effect with BMP2.
Conclusions:
- Trapidil promotes osteogenesis in vitro and in vivo by upregulating bone morphogenetic protein receptor (BMPR) activity and enhancing BMP signaling.
- Inhibition of osteogenesis by PDGFR signaling may involve attenuated BMPR activity.
More Related Videos
05:10Improved Methodology for Studying Postnatal Osteogenesis via Intramembranous Ossification in a Murine Bone Marrow Injury Model
Published on: February 7, 2025
09:26An Efficient and Reproducible Protocol for Distraction Osteogenesis in a Rat Model Leading to a Functional Regenerated Femur
Published on: October 23, 2017
Related Concept Videos
Bacterial Signaling
Yeast Signaling
Endocrine Signaling
What is Cell Signaling?
Cell-surface Signaling
Intracellular Signaling Cascades